At this year’s NANETS meeting, new data highlights progress for those with carcinoid syndrome. Global Product Lead, Tom Beveridge, shares how advancing the science of somatostatin receptor agonism is shaping the future of care

Elevating care for people with acromegaly means looking at the whole patient journey. Our Chief Commercial Officer, Isabel Kalofonos, discusses ways to address barriers, support providers, and share resources that can help the community.

Patient insight doesn’t just inform our work—it drives it. Read about our approach to patient driven innovation and development from Stephanie Kallay, Director of Patient Advocacy.

In honor of Women’s History Month, Chief Corporate Affairs Officer Jacqui Kirby reflects on the inspiring female leaders who have shaped the pharmaceutical industry.

November 1 is Acromegaly Awareness Day—an important moment in time to raise awareness and provide support for those impacted by it. Hear Dana Pizzuti, Chief Medical and Development Officer, reflect on the significant progress we have made toward developing a new generation of acromegaly treatment.